Is BBIXF or JNJ a better dividend investment in 2026?

BBIXF currently yields 1666.67% with a 5% 5-year dividend growth rate. JNJ yields 2.14% with 5.8% growth. The better choice depends on your goal: BBIXF offers higher current income.

What is the dividend yield difference between BBIXF and JNJ?

BBIXF has a forward dividend yield of 1666.67% ($2.00/share annually). JNJ yields 2.14% ($5.20/share annually). The yield gap is 1664.53 percentage points.

Home › Compare › BBIXF vs JNJ

BBIXF vs JNJ: Dividend Comparison 2026

BBIXF yields 1666.67% · JNJ yields 2.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BBIXF wins by $1839785666.23M in total portfolio value

INVESTMENT

TIME HORIZON10 years

BBIXF

● Live price

1666.67%

Share price

$0.12

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1839785666.26M

Annual income

$1,645,561,548,268,653.00

Full BBIXF calculator →

JNJ

Johnson & Johnson

● Live price

2.14%

Share price

$242.49

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.5K

Annual income

$4,749.88

Full JNJ calculator →

Portfolio growth — BBIXF vs JNJ

📍 BBIXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BBIXF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BBIXF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BBIXF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BBIXF

Annual income on $10K today (after 15% tax)

$141,666.67/yr

After 10yr DRIP, annual income (after tax)

$1,398,727,316,028,355.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$182.28/yr

After 10yr DRIP, annual income (after tax)

$4,037.40/yr

At 15% tax rate, BBIXF beats the other by $1,398,727,316,024,317.50/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BBIXF + JNJ for your $10,000?

BBIXF: 50%JNJ: 50%

100% JNJ50/50100% BBIXF

Portfolio after 10yr

$919892833.14M

Annual income

$822,780,774,136,701.50/yr

Blended yield

89.44%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BBIXF

No analyst data

Altman Z

-19.8

Piotroski

2/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-5.7% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BBIXF buys

JNJ buys

No recent congressional trades found for BBIXF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBBIXFJNJ

Forward yield	1666.67% ✓	2.14%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$1839785666.26M ✓	$30.5K
Annual income after 10y	$1,645,561,548,268,653.00 ✓	$4,749.88
Total dividends collected	$1825787439.21M ✓	$15.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: BBIXF vs JNJ ($10,000, DRIP)

Year	BBIXF Portfolio	BBIXF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$177,367	$166,666.67	$10,594	$274.49	+$166.8K → BBIXF
2	$2,952,503	$2,762,720.66	$11,294	$360.69	+$2.94M → BBIXF
3	$46,139,686	$42,980,507.73	$12,133	$476.91	+$46.13M → BBIXF
4	$677,098,258	$627,728,794.51	$13,156	$635.42	+$677.09M → BBIXF
5	$9,333,745,461	$8,609,250,324.41	$14,432	$854.61	+$9333.73M → BBIXF
6	$120,900,966,251	$110,913,858,608.07	$16,056	$1,162.76	+$120900.95M → BBIXF
7	$1,472,054,345,780	$1,342,690,311,890.92	$18,175	$1,604.53	+$1472054.33M → BBIXF
8	$16,853,789,214,559	$15,278,691,064,574.45	$21,009	$2,252.68	+$16853789.19M → BBIXF
9	$181,517,867,281,133	$163,484,312,821,554.84	$24,911	$3,229.73	+$181517867.26M → BBIXF
10	$1,839,785,666,259,465	$1,645,561,548,268,653.00	$30,458	$4,749.88	+$1839785666.23M → BBIXF

BBIXF vs JNJ: Complete Analysis 2026

BBIXF — Stock

Bonus BioGroup Ltd., a biotechnology company, develops technology solutions to generate tissue-regenerating bone grafts. It develops tissue-regenerating bone grafts from cells derived from the patient's own cells for the treatment of skeletal disorders, such as bone trauma and arthritis. The company's products include BonoFill injectable bone graft that is suitable for bone repair applications, including jaw bone cysts; and BonoFill pre-designed bone graft, which is used to repair large and segmental bone defects. Its products in pipeline comprise bone grafts for maxillofacial and orthopedic applications; novel nanomaterials technology for tissue regeneration; and large vascularized bone grafts. The company was formerly known as Oceana Advanced Industries Ltd. and changed its name to Bonus BioGroup Ltd. Bonus BioGroup Ltd. was founded in 1981 and is based in Haifa, Israel.

Full BBIXF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this BBIXF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BBIXF vs SCHD BBIXF vs JEPI BBIXF vs O BBIXF vs KO BBIXF vs MAIN BBIXF vs ABBV BBIXF vs MRK BBIXF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.